Living with Multiple Myeloma. – Understanding Smouldering Multiple Myeloma


In this podcast, Dr Gerard Crotty, Consultant Hematologist explains Monoclonal Gammapathy of Undermined Significance (MGUS) a non-cancerous condition of the plasma cells and the slow growing cancerous process or early form of myeloma, Smouldering Multiple Myeloma.

Dr Crotty explains how treatment outside a clinical trial is not indicated in patients with either condition, however close monitoring is required.

For patients living with MGUS only a small no of patients will progress to Multiple Myeloma and will require treatment. For patients with Smouldering Multiple Myeloma abnormal cells can be detected in the bone marrow and an abnormal protein can be detected in the blood or urine but patients have none of the typical symptoms of active disease and monitoring regularly for signs that may indicate progression to active disease is the mainstay of management.

Understanding MGUS or SMM can be challenging for patients, Dr Crotty highlights the key symptoms patients need to report to their treating team.

Multiple Myeloma Ireland:




This podcast has been produced by Fuzion Communications.


Need more information from us?

Stay Updated

Speak confidentially with our support services team for information and support.

Call +353 86 022 6992 or email

Together we can help patients & carers of multiple myeloma.

2020 © All rights reserved of Multiple Myeloma Ireland | Multiple Myeloma Patient & Carer Support
Multiple Myeloma Ireland c/o Cancer Centre, Haem/Onc Day Unit, Limerick University Hospital.
Loading please wait